normal plasma arginin esteras hageman factor factor xii prekallikreinkininogen system cystic fibrosi previou investig suggest biolog activ plasma prekallikrein defect cystic fibrosi contrast differ demonstr normal cystic fibrosi plasma esterolyt activ synthet substrat ptoluen sulfonylarginin methyl ester tame evolv normal cystic fibrosi plasma treat chloroform ellag acid measur gener plasma kallikrein addit plasma prekallikrein fletcher factor high molecular weight kininogen fitzgerald factor substrat plasma kallikrein normal thu concept cystic fibrosi associ abnorm plasma kallikreinkinin system could support